Results 131 to 140 of about 78,306 (357)

Efficient cobalamin uptake and cycling contribute to the lack of cobalamins in the surface cobalt‐binding ligand pool in the North Pacific

open access: yesLimnology and Oceanography Letters, EarlyView.
Abstract Cobalt is a central component of cobalamins, which are nutrients essential for various metabolic processes in marine organisms. Dissolved cobalt in seawater is mostly bound to organic ligands, and the prevailing assumption to date is that these ligands are cobalamin‐related compounds, yet the identity and impact of these ligands on cobalt ...
Jiwoon Park   +6 more
wiley   +1 more source

Levodopa–Entacapone–Carbidopa Intrajejunal Infusion in Advanced Parkinson's Disease – Interim Analysis of the ELEGANCE Study

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Levodopa–entacapone–carbidopa intestinal gel (LECIG) was introduced in 2018 as a device‐aided therapy for advanced Parkinson's disease (PD). Objectives The ELEGANCE study (NCT05043103) is gathering real‐world data on long‐term efficacy, safety and patient‐reported outcomes with LECIG from 13 European countries.
Daniel Weiss   +10 more
wiley   +1 more source

A blueprint for fortification planning and programming: Lessons learned from an analytical review of existing fortification frameworks

open access: yesMaternal &Child Nutrition, EarlyView., 2023
The proposed Fortification Blueprint provides a call to action (and a mechanism to operationalize the call) around the need to take a renewed look at fortification programmes to address historically persistent challenges. Abstract With multiple food fortification frameworks, countries can find it challenging to determine optimal methods for planning ...
Roopa Darwar   +4 more
wiley   +1 more source

Characterization of Vitamin B12 Supplementation and Correlation with Clinical Outcomes in a Large Longitudinal Study of Early Parkinson's Disease. [PDF]

open access: yes, 2019
ObjectiveIn Parkinson's disease (PD), vitamin B12 levels are lower, and comorbid B12 deficiency has been associated with the development of neuropathy and early gait instability.
Christine, Chadwick W   +3 more
core  

Vitamin B12 deficiency and neuropsychiatric symptoms in Lebanon: A cross-sectional study of vegans, vegetarians, and omnivores.

open access: yesPLoS ONE
BackgroundVitamin B12 deficiency is responsible for a variety of complications, particularly neurological/neuropsychiatric complications, including depression, irritability, paresthesia and insomnia. Since vitamin B12 is found in animal-derived products,
Omar Al Jassem   +7 more
doaj   +1 more source

Opicapone in Parkinson's Disease on Levodopa‐Carbidopa Intestinal Gel Treatment: A Pilot, Randomized Study

open access: yesMovement Disorders Clinical Practice, EarlyView.
ABSTRACT Background Levodopa‐carbidopa intestinal gel infusion (LCIG) is an effective therapy for advanced Parkinson's disease (PD). Opicapone (OPC) is an enzyme inhibitor that enhances the bioavailability of levodopa in the brain. Objectives This study evaluates the effect of Opicapone addition in PD‐LCIG patients, assessing its impact on motor ...
Fabiana Colucci   +9 more
wiley   +1 more source

Lhermitte's sign and vitamin B12 deficiency: case report

open access: yesSão Paulo Medical Journal
CONTEXT AND OBJECTIVE: Lhermitte's sign, a classical neurological sign, is a rare manifestation of vitamin B12 deficiency. The aim here was to report on a case of an elderly patient with vitamin B12 deficiency whose first clinical manifestation was the ...
Hélio Afonso Ghizoni Teive   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy